Project Details
Abstract
Circulating tumor cells (CTCs) represent a minimally invasive window into tumor biology and have growing relevance for understanding metastasis, monitoring treatment response, and detecting emerging resistance. Advances in microfluidics now allow efficient label‑free CTC capture, enumeration, and single‑cell downstream analysis. CityUHK’s Cellomics platform has demonstrated high performance in both research and clinical settings, with regulatory approvals in China and CE‑IVD certification in the European Union. The technology is already deployed in multiple hospitals, supporting clinical decision‑making and translational studies.
Submitting Institute Name
Hamad Bin Khalifa University (HBKU)
| Sponsor's Award Number | HBKU-INT-VPR-JFI-03 |
|---|---|
| Proposal ID | HBKU-OVPR-SIC-01-19 |
| Status | Active |
| Effective start/end date | 3/09/26 → 2/09/28 |
Primary Theme
- Artificial Intelligence
Primary Subtheme
- AI - Healthcare
Secondary Theme
- None
Secondary Subtheme
- None
Keywords
- None
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.